LuMind IDSC Supported the T21RS COVID-19 Initiative’s International Survey on Patients with COVID-19 and Down Syndrome
May 3, 2021 LuMind IDSC supported the T21RS COVID-19 Initiative that brought about the original survey and the resulting analysis,
May 3, 2021 LuMind IDSC supported the T21RS COVID-19 Initiative that brought about the original survey and the resulting analysis,
We have received several questions about recommendations on travel for people with Down syndrome, in light of novel coronavirus (COVID-19).Source:
My family and I have been vaccinated. Is it safe to travel?Source: Brian Chicoine, MD
This document contains slides from a webinar on mental health causes for behavior change during a pandemic. It was presented
In this video, Brian Chicoine, M.D. and Katie Frank, Ph.D., OTR/L discuss behavior changes happening during the pandemic, including strategies
Date: 3/2/2021
Today, an important and timely COVID-19 and Down Syndrome Resource (“Resource”) was published by a consortium of national Down syndrome organizations: the Down Syndrome Medical Interest Group-USA (DSMIG-USA), Global Down Syndrome Foundation (GLOBAL), LuMind IDSC Foundation (LuMind IDSC), National Down Syndrome Congress (NDSC), National Down Syndrome Society (NDSS), and National Task Group on Intellectual Disabilities and Dementia Practices (NTG).
El recurso se basa en la publicación de “COVID & SD Preguntas y Respuestas” y se centra en información nueva
This Resource builds upon the publication of the Q&A on COVID-19 & Down Syndrome and focuses on new and updated
Health conditions, immune dysfunction, and premature aging associated with trisomy 21 (Down syndrome, DS) may impact the clinical course of
As with all vaccines, there is the potential to experience side effects after getting the COVID-19 vaccine. This is true